SEC Company Response from Aspira Women's Health Inc. (AWHL) (CIK 0000926617) (AWHL) — Oct 5, 2007
Aspira Women's Health Inc. (AWHL) (CIK 0000926617)
Date: Oct. 5, 2007 · CIK: 0000926617 · Accession: 0000950134-07-020959
AI Filing Summary & Sentiment
Reasoning
Referenced dates: September 24, 2007
Letter
Washington, D.C. 20549 Attn: Kate Tillan SEC Comments of September 24, 2007
Re:
Dear Ms. Tillan:
This letter is in response to your comment letter dated September 24, 2007. The company acknowledges that:
•
the company is responsible for the adequacy and accuracy of the disclosure in the filing:
•
staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
•
the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/ Debra Young
Show Raw Text
CORRESP
1
filename1.htm
corresp
October 5, 2007
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Kate Tillan
Re:
SEC Comments of September 24, 2007
Dear Ms. Tillan:
This letter is in response to your comment letter dated September 24, 2007. The company
acknowledges that:
•
the company is responsible for the adequacy and accuracy of the disclosure in the
filing:
•
staff comments or changes to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and
•
the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/ Debra Young
Debra Young
Vice President & Chief Financial Officer